Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Location & Ethnicity Affect Manifestations of Primary Sjogren’s Syndrome

Marilynn Larkin  |  December 12, 2016

“Geoepidemiology and ethnicity should be considered as key variables that should be analyzed in multiethnic studies of patients with primary Sjogren’s syndrome, which is the systemic autoimmune disease with the most unbalanced gender ratio, with nearly 14 women affected per one man,” Dr. Ramos-Casals concluded.

Sjogren’s researcher Dr. Qing Yu of the Harvard-affiliated Forsyth Institute in Cambridge, Massachusetts, told Reuters Health, “This study . . . provides crucial new evidence supporting a contribution of both genetic and environmental factors to the disease pathologies and manifestations.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“Knowledge of the varied prevalence and pattern of disease manifestations in different ethnic and geographical groups could be useful for clinicians in the diagnosis of Sjogren’s disease, a challenging process that takes three to four years on average,” she said by email.

“More importantly,” Dr. Yu concluded, “the information from this study will no doubt facilitate further clinical, epidemiological and basic research on Sjogren’s disease to benefit millions of patients.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Reference

Brito-Zerón P, Acar-Denizli N, Zeher M, et al. Influence of geolocation and ethnicity on the phenotypic expression of primary Sjögren’s syndrome at diagnosis in 8310 patients: a cross-sectional study from the Big Data Sjögren Project Consortium. Ann Rheum Dis. 2016 Nov 29. pii: annrheumdis-2016-209952. [Epub ahead of print]

Page: 1 2 | Single Page
Share: 

Filed under:ConditionsSjögren’s Disease Tagged with:ethnicityGeolocationSjogren's

Related Articles

    Systemic Sjögrens: More Than a Sicca Disease

    November 1, 2014

    Differences in its epidemiologic, clinical and immunologic features underscore need for a homogeneous diagnostic and therapeutic approach

    Sjögren’s Awareness Month: Educate Patients, Families, Caregivers

    April 10, 2017

    April is Sjögren’s Awareness Month, a time for rheumatologists to help educate the public and themselves about Sjögren’s syndrome and its diagnosis. With newly published clinical practice guidelines, Nancy Carteron, MD, encourages rheumatologists to be first responders for this patient population…

    Watch Those Eyes

    December 1, 2007

    What you need to know about Uveitis in Rheumatic Diseases

    Researchers Look for Therapeutic Clues to Sjögrens Syndrome in Neural Pathways

    November 1, 2013

    Beyond biologic agents, scientists study cytokines, chemokines, and the interface between inflammatory and neural/secretory pathways

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences